| 2025-04-08 | -75.7% | M&A | Stocktwits | Bluejay Diagnostics Raises $3.7M Through Warrant Deal, Stock Slides After-Hours While Retail Interest Surges - Stocktwits |
| 2025-10-09 | +73.6% | legal | SEC EDGAR | BJDX 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-10-09 | +73.6% | earnings | RagingBull | Bluejay Diagnostics (BJDX) Stock Rockets on Expanded Partnership: A Game-Changer for Sepsis Testing? - RagingBull |
| 2025-10-09 | +73.6% | news | StocksToTrade | Is It Time to Buy Bluejay Diagnostics Stock? - StocksToTrade |
| 2025-10-09 | +73.6% | news | Yahoo Finance | Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Yahoo Finance |
| 2025-10-09 | +73.6% | expansion | Investing.com | Bluejay Diagnostics stock soars after expanding manufacturing partnership - Investing.com |
| 2025-10-09 | +73.6% | expansion | parameter.io | Bluejay Diagnostics, Inc. (BJDX) Stock: Soars 105% as Expanded Partnership with SanyoSeiko Accelerates Symphony Commercialization - parameter.io |
| 2024-12-04 | +69.4% | legal | SEC EDGAR | BJDX 8-K: 8.01 (SEC Filing) |
| 2023-07-21 | +65.1% | news | Seeking Alpha | Bluejay Diagnostics announces 1-for-20 reverse stock split to regain Nasdaq compliance |
| 2023-07-21 | +65.1% | legal | SEC EDGAR | BJDX 8-K: 3.03, 5.03, 5.07, 8.01 (SEC Filing) |
| 2023-12-27 | -54.6% | legal | SEC EDGAR | BJDX 8-K: 8.01 and (SEC Filing) |
| 2023-07-23 | +42.1% | news | TradingView | BJDX Stock Price and Chart — NASDAQ:BJDX - TradingView |
| 2024-11-13 | -30.9% | news | Seeking Alpha | Bluejay Diagnostics announces 1 for 50 reverse stock split |
| 2023-12-28 | -30.2% | news | Seeking Alpha | Bluejay Diagnostics stock plummets on pricing $3.5M offering of common stock |
| 2024-06-17 | -29.1% | news | Seeking Alpha | Bluejay Diagnostics announces 1-for-8 reverse stock split |
| 2023-08-25 | -19.6% | legal | Seeking Alpha | Bluejay Diagnostics to raise $1.59M to fund FDA approval process |
| 2023-05-19 | -18.8% | legal | SEC EDGAR | BJDX 8-K: 8.01 and (SEC Filing) |
| 2025-04-09 | -18.2% | legal | SEC EDGAR | BJDX 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2025-10-14 | +16.9% | legal | SEC EDGAR | BJDX 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2023-03-20 | -16.2% | earnings | Seeking Alpha | Bluejay Diagnostics GAAP EPS of -$0.46, revenue of $0.25M |
| 2023-03-20 | -16.2% | legal | SEC EDGAR | BJDX 8-K: 2.02 and (SEC Filing) |
| 2023-10-26 | -15.7% | legal | SEC EDGAR | BJDX 8-K: 1.01 and (SEC Filing) |
| 2021-11-11 | -14.7% | earnings | MarketBeat | Bluejay Diagnostics (BJDX) Stock Price, News & Analysis - MarketBeat |
| 2025-04-07 | -14.7% | M&A | Seeking Alpha | Bluejay Diagnostics slumps after raising $3.7M through warrant exercise deal |
| 2025-06-04 | -14.1% | legal | SEC EDGAR | BJDX 8-K: 8.01 and (SEC Filing) |
| 2025-06-04 | -14.1% | news | Intellectia AI | BJDX Forecast — Price Prediction for 2026. Should I Buy BJDX? - Intellectia AI |
| 2023-10-02 | -12.2% | legal | SEC EDGAR | BJDX 8-K: 5.02 (SEC Filing) |
| 2024-05-31 | +12.2% | legal | SEC EDGAR | BJDX 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2022-03-24 | -11.9% | executive | Seeking Alpha | Bluejay Diagnostics picks industry veteran for CFO role |
| 2022-11-09 | -11.4% | earnings | Seeking Alpha | Bluejay Diagnostics GAAP EPS of -$0.15 |
| 2022-01-26 | -11.2% | news | Benzinga | Bluejay Diagnostics Stock Short Interest Report | NASDAQ:BJDX - Benzinga |
| 2023-10-16 | +10.8% | legal | SEC EDGAR | BJDX 8-K: 5.02 (SEC Filing) |
| 2024-10-16 | -10.4% | news | Investing.com | Bluejay Diagnostics stock hits 52-week low at $0.1 - Investing.com |
| 2023-11-21 | -9.6% | news | Seeking Alpha | Bluejay Diagnostics files to sell common stocks, warrants |
| 2023-01-27 | +9.5% | legal | SEC EDGAR | BJDX 8-K: 5.02 and (SEC Filing) |
| 2021-11-16 | -9.2% | legal | SEC EDGAR | BJDX 8-K: 1.01, 5.02, 8.01 (SEC Filing) |
| 2025-12-23 | -8.9% | news | Trefis | Bluejay Diagnostics Stock Plummets 37% With 11-Day Losing Streak - Trefis |
| 2024-08-28 | -8.5% | legal | SEC EDGAR | BJDX 8-K: 3.01, 5.03, 8.01 (SEC Filing) |
| 2026-04-02 | +8.4% | news | Xã Vĩnh Công | Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Viral Momentum Stocks - Xã Vĩnh Công |
| 2025-11-10 | +8.4% | earnings | Stock Titan | Bluejay Diagnostics (NASDAQ: BJDX) sets 2027 510(k) submission goal; SYMON-II ~50% enrolled - Stock Titan |
| 2022-07-26 | -8.2% | earnings | Seeking Alpha | Bluejay Diagnostics GAAP EPS of -$0.10, revenue of $249.04M |
| 2022-07-26 | -8.2% | legal | SEC EDGAR | BJDX 8-K: 2.02 and (SEC Filing) |
| 2023-08-11 | -7.4% | news | Seeking Alpha | Bluejay Diagnostics regains compliance with Nasdaq listing standards |
| 2022-11-08 | -7.1% | legal | SEC EDGAR | BJDX 8-K: 2.02 and (SEC Filing) |
| 2025-10-23 | -6.7% | news | Seeking Alpha | Bluejay Diagnostics files to sell 6.93M shares of common stock for holders |
| 2025-05-28 | -6.4% | legal | SEC EDGAR | BJDX 8-K: 5.02 and (SEC Filing) |
| 2022-09-14 | -6.4% | news | Seeking Alpha | Bluejay Diagnostics (BJDX) Investor Presentation - Slideshow |
| 2025-08-15 | +6.4% | legal | SEC EDGAR | BJDX 8-K: 8.01 (SEC Filing) |
| 2023-11-10 | +6.2% | earnings | Seeking Alpha | Bluejay Diagnostics GAAP EPS of -$2.08 |
| 2024-04-02 | -6.1% | legal | SEC EDGAR | BJDX 8-K: 5.02 and 8.01 (SEC Filing) |
| 2022-04-01 | +6.0% | legal | SEC EDGAR | BJDX 8-K: 5.02 and (SEC Filing) |
| 2025-03-31 | -5.9% | earnings | qz.com | Bluejay Diagnostics Inc. (BJDX) reports earnings - qz.com |
| 2022-04-20 | +5.9% | earnings | Seeking Alpha | Bluejay Diagnostics GAAP EPS of -$0.10 |
| 2022-04-20 | +5.9% | legal | SEC EDGAR | BJDX 8-K: 2.02 and (SEC Filing) |
| 2026-02-17 | -5.9% | news | GlobeNewswire | Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026 |
| 2026-02-17 | -5.9% | earnings | Stock Titan | Sepsis test maker builds supply for 10M rapid kits as key trial advances - Stock Titan |
| 2024-06-28 | -5.8% | legal | SEC EDGAR | BJDX 8-K: 1.01, 8.01 (SEC Filing) |
| 2021-12-15 | -5.8% | news | StockInvest.us | Bluejay Diagnostics Stock Price Forecast. Should You Buy BJDX? - StockInvest.us |
| 2023-04-06 | -5.6% | news | CoinCodex | Bluejay Diagnostics, Inc. (BJDX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex |
| 2023-05-10 | +5.0% | earnings | Seeking Alpha | Bluejay Diagnostics GAAP EPS of -$0.12 |
| 2023-05-10 | +5.0% | legal | SEC EDGAR | BJDX 8-K: 2.02 and (SEC Filing) |
| 2026-03-11 | +4.8% | news | GlobeNewswire | NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics |
| 2025-05-13 | -4.7% | news | Intellectia AI | BJDX Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2024-05-11 | +4.6% | earnings | MarketBeat | Bluejay Diagnostics (BJDX) Stock Forecast and Price Target 2026 - MarketBeat |
| 2022-02-06 | -4.6% | analyst | ChartMill | BJDX Forecast, Price Target & Analyst Ratings | BLUEJAY DIAGNOSTICS INC (NASDAQ:BJDX) - ChartMill |
| 2022-02-05 | -4.6% | news | ChartMill | BJDX Stock Price, Quote & Chart | BLUEJAY DIAGNOSTICS INC (NASDAQ:BJDX) - ChartMill |
| 2021-12-16 | +4.5% | earnings | Seeking Alpha | Bluejay Diagnostics reports Q3 results |
| 2021-12-16 | +4.5% | legal | SEC EDGAR | BJDX 8-K: 2.02 and (SEC Filing) |
| 2025-12-29 | +4.5% | news | Stock Titan | Enough IL-6 test antibodies made to power 9M diagnostic cartridges - Stock Titan |
| 2024-01-02 | -4.4% | legal | SEC EDGAR | BJDX 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-03-12 | -4.3% | news | GlobeNewswire | Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting |
| 2026-03-17 | -4.0% | legal | SEC EDGAR | BJDX 8-K: 1.01, 3.02 (SEC Filing) |
| 2024-06-20 | +3.2% | legal | SEC EDGAR | BJDX 8-K: 3.03, 5.03, 5.07, 8.01 (SEC Filing) |
| 2026-04-20 | -3.1% | news | Stock Titan | Board seeks flexible reverse split, plan increase at Bluejay Diagnostics (NASDAQ: BJDX) - Stock Titan |
| 2026-04-20 | -3.1% | news | ChartMill | BJDX Ownership | BLUEJAY DIAGNOSTICS INC (NASDAQ:BJDX) - ChartMill |
| 2026-04-20 | -3.1% | news | Meyka | Why Is Bluejay Diagnostics, Inc. (BJDX) Stock Down Today? - Meyka |
| 2022-01-31 | -3.1% | earnings | Seeking Alpha | Bluejay Diagnostics stock jumps 11% on FDA Pre-submission filing for Symphony IL-6 test |
| 2026-04-07 | -3.1% | news | GlobeNewswire | Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial |
| 2026-04-07 | -3.1% | earnings | Stock Titan | Bluejay nears finish line in sepsis test study with 624 patients - Stock Titan |
| 2026-04-07 | -3.1% | earnings | Stock Titan | SYMON-II sepsis trial nears full enrollment at Bluejay (NASDAQ: BJDX) - Stock Titan |
| 2023-08-10 | -3.0% | legal | SEC EDGAR | BJDX 8-K: 8.01 and (SEC Filing) |
| 2023-08-28 | -2.9% | legal | SEC EDGAR | BJDX 8-K: 1.01, 3.02 (SEC Filing) |
| 2022-03-10 | -2.8% | earnings | Seeking Alpha | Bluejay Diagnostics GAAP EPS of -$0.09 |
| 2022-03-10 | -2.8% | legal | SEC EDGAR | BJDX 8-K: 2.02 and (SEC Filing) |
| 2024-11-18 | -2.6% | legal | SEC EDGAR | BJDX 8-K: 3.03, 5.03, 5.07, 8.01 (SEC Filing) |
| 2026-01-27 | +2.4% | news | GlobeNewswire | Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split |
| 2026-01-27 | +2.4% | news | Seeking Alpha | Bluejay Diagnostics announces 1-for-4 reverse stock split |
| 2026-01-27 | +2.4% | news | Yahoo Finance | Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - Yahoo Finance |
| 2026-01-27 | +2.4% | news | Investing.com | Bluejay Diagnostics announces 1-for-4 reverse stock split - Investing.com |
| 2026-01-27 | +2.4% | news | Stock Titan | Bluejay Diagnostics cuts share count to ~708K in 1-for-4 reverse split - Stock Titan |
| 2026-02-20 | -2.2% | news | GlobeNewswire | Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised |
| 2026-02-20 | -2.2% | news | TradingView | Bluejay Diagnostics says all prefunded warrants exercised; ~972,000 shares outstanding, 1.5M cash-exercise warrants - TradingView |
| 2026-02-20 | -2.2% | news | Stock Titan | Medical diagnostics firm ends prefunded warrants, flags 13G share confusion - Stock Titan |
| 2026-01-30 | -1.9% | legal | SEC EDGAR | BJDX 8-K: 3.03, 5.03, 5.07, 8.01 (SEC Filing) |
| 2022-01-12 | -1.8% | analyst | Seeking Alpha | Bluejay Diagnostics gains after Dawson James imitated with a Buy rating |
| 2022-01-13 | -1.6% | news | Seeking Alpha | Bluejay completes 90 subjects in prospective study for COVID-19 test |
| 2025-07-28 | +1.6% | legal | SEC EDGAR | BJDX 8-K: 1.01 and (SEC Filing) |
| 2021-12-07 | -1.6% | news | Seeking Alpha | Bluejay Diagnostics extends gains to recover from post-IPO slump |
| 2022-07-31 | -1.5% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Bluejay Diagnostics (BJDX) - Zacks Investment Research |
| 2023-08-16 | +1.2% | earnings | Seeking Alpha | Bluejay Diagnostics GAAP EPS of -$2.75 |
| 2023-08-16 | +1.2% | legal | SEC EDGAR | BJDX 8-K: 2.02 and (SEC Filing) |
| 2026-03-06 | -1.1% | news | GlobeNewswire | Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook |
| 2026-03-06 | -1.1% | legal | SEC EDGAR | BJDX 8-K: 2.02 and (SEC Filing) |
| 2026-03-06 | -1.1% | earnings | Stock Titan | Bluejay’s 20-minute sepsis test drives 2026 plan and $20M cash goal - Stock Titan |
| 2022-03-28 | +0.6% | legal | SEC EDGAR | BJDX 8-K: 5.02 and (SEC Filing) |
| 2022-06-09 | +0.6% | expansion | Seeking Alpha | Bluejay climbs 29% on FDA agreement for product candidate |
| 2023-11-09 | -0.2% | legal | SEC EDGAR | BJDX 8-K: 2.02 and (SEC Filing) |
| 2021-11-10 | — | news | Seeking Alpha | Bluejay Diagnostics shares drop 46% in IPO |
| 2021-11-10 | — | news | Seeking Alpha | Bluejay Diagnostics sets pricing for upsized $21.6M IPO |
| 2021-11-10 | — | news | Stock Titan | Latest BJDX News - Bluejay Diagnostics, Inc. Announces Complet... - Stock Titan |